Mingshu Xiao

Prof. Dr. Mingshu Xiao

Nanjing University of Science and Technology, Nanjing, Jiangsu, China
orcid
Nanjing University of Science and Technology

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Chemical Reviews
Verified
Journal Article
Closed access
MXMingshu Xiao
Mingshu Xiao
WLWei Lai
Wei Lai
TMTiantian Man
Tiantian Man
BCBinbin Chang
Binbin Chang
LLLi Li
Li Li
HPHao Pei
Hao Pei

1 March 2014 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
YMYuqing Miao
Yuqing Miao
LOLei Ouyang
Lei Ouyang
SZShilin Zhou
Shilin Zhou
LXLina Xu
Lina Xu
ZYZhuoyuan Yang
Zhuoyuan Yang
RORuizhuo Ouyang
Ruizhuo Ouyang

1 February 2018 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
RZRuibo Zhong
Ruibo Zhong
QTQian Tang
Qian Tang
SWShaopeng Wang
Shaopeng Wang
Hongbo ZhangHongbo Zhang
Hongbo Zhang
FZFeng Zhang
Feng Zhang
HPHao Pei
Hao Pei

9 September 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
MXMingshu Xiao
Mingshu Xiao
KZKui Zou
Kui Zou
LLLi Li
Li Li
LWLihua Wang
Lihua Wang
YTYang Tian
Yang Tian
HPHao Pei
Hao Pei

2 December 2022 in Science Advances
Verified
Journal Article
Open access
YSYueyang Sun
Yueyang Sun
JSJiajia Sun
Jiajia Sun
MXMingshu Xiao
Mingshu Xiao
WLWei Lai
Wei Lai
LLLi Li
Li Li
HPHao Pei
Hao Pei
Nanosized artificial antigen-presenting cells (aAPCs) with efficient signal presentation hold great promise for in vivo adoptive cell therapy. Here, we used DNA origami nanostructures as two-dimensional scaffolds to regulate the spatial presentation of activating ligands at nanoscale to construct high-effective aAPCs. The DNA origami–based aAPC comprises costimulatory ligands anti-CD28 antibody anchored at three vertices and T cell receptor (TCR) ligands peptide–major histocompatibility complex (pMHC) anchored at three edges with varying density. The DNA origami scaffold enables quantitative analysis of ligand-receptor interactions in T cell activation at the single-particle, single-molecule resolution. The pMHC-TCR–binding dwell time is increased from 9.9 to 12.1 s with increasing pMHC density, driving functional T cell responses. In addition, both in vitro and in vivo assays demonstrate that the optimized DNA origami–based aAPCs show effective tumor growth inhibiting capability in adoptive immunotherapy. These results provide important insights into the rational design of molecular vaccines for cancer immunotherapy.

13 March 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
HYHaihong Yang
Haihong Yang
MXMingshu Xiao
Mingshu Xiao
WLWei Lai
Wei Lai
YWYing Wan
Ying Wan
LLLi Li
Li Li
HPHao Pei
Hao Pei